share_log

424B5: Prospectus

424B5: Prospectus

424B5:募資說明書
美股SEC公告 ·  07/11 21:03
牛牛AI助理已提取核心訊息
SeaStar Medical Holding Corporation, a medical technology company, has announced a registered direct offering of 947,868 shares of its common stock at a price of $10.55 per share. The offering is accompanied by a concurrent private placement of unregistered common stock purchase warrants, exercisable at $10.55, immediately upon issuance and expiring five years from the date of issuance. The purchase price for each share of common stock is also set at $10.55. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close on or about July 11, 2024, subject to customary closing conditions. The proceeds, before expenses, are estimated to be approximately $9.3 million and are intended for the redemption and repayment of certain notes, as well as funding the company's development and commercialization activities and general corporate purposes. This offering follows SeaStar Medical's recent compliance with Nasdaq's minimum market value requirement and its ongoing efforts to maintain its listing on the exchange.
SeaStar Medical Holding Corporation, a medical technology company, has announced a registered direct offering of 947,868 shares of its common stock at a price of $10.55 per share. The offering is accompanied by a concurrent private placement of unregistered common stock purchase warrants, exercisable at $10.55, immediately upon issuance and expiring five years from the date of issuance. The purchase price for each share of common stock is also set at $10.55. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close on or about July 11, 2024, subject to customary closing conditions. The proceeds, before expenses, are estimated to be approximately $9.3 million and are intended for the redemption and repayment of certain notes, as well as funding the company's development and commercialization activities and general corporate purposes. This offering follows SeaStar Medical's recent compliance with Nasdaq's minimum market value requirement and its ongoing efforts to maintain its listing on the exchange.
醫療科技公司SeaStar Medical Holding Corporation宣佈以每股10.55美元的價格註冊直接發行947,868股普通股。發行配套非公開上市普通股認購權,每股認購價爲10.55美元,發行後立即行權,行權期限爲發行日起五年。每股普通股的發行價格也定爲10.55美元。Collei維科證券公司將擔任本次發行的獨家配售代理商,預計2024年7月11日或前後完成,目前遵守慣例的收盤條件。預計募集資金淨額爲約930萬美元,用於贖回和償還某些票據,以及資助公司的開發和商業化活動以及一般企業用途。此次發行是SeaStar Medical最近遵守Nasdaq最低市值要求並維持其在該交易所上市的持續努力之後進行的。
醫療科技公司SeaStar Medical Holding Corporation宣佈以每股10.55美元的價格註冊直接發行947,868股普通股。發行配套非公開上市普通股認購權,每股認購價爲10.55美元,發行後立即行權,行權期限爲發行日起五年。每股普通股的發行價格也定爲10.55美元。Collei維科證券公司將擔任本次發行的獨家配售代理商,預計2024年7月11日或前後完成,目前遵守慣例的收盤條件。預計募集資金淨額爲約930萬美元,用於贖回和償還某些票據,以及資助公司的開發和商業化活動以及一般企業用途。此次發行是SeaStar Medical最近遵守Nasdaq最低市值要求並維持其在該交易所上市的持續努力之後進行的。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。